Fimbriae, particularly the FimA protein, contribute to NAFLD progression by binding to TLR2, CR3, and CXCR4, thereby inducing diverse immune-inflammatory responses. Here, CRIPTO3 is linked to metabolic dysfunction-associated steatotic liver disease.